{
    "2018-10-19": [
        [
            {
                "time": "",
                "original_text": "智飞生物:4价HPV疫苗保持快速增长,行业恢复好于预期",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "HPV疫苗",
                        "快速增长",
                        "行业恢复"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物（300122）业绩点评——业绩增长靓丽，HPV疫苗保持快速增长",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "业绩增长",
                        "HPV疫苗",
                        "快速增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【西南医药朱国广团队】智飞生物（300122）业绩略超预期，公司延续高速增长",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "业绩超预期",
                        "高速增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：业绩符合预期 期待国产疫苗恢复",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "业绩符合预期",
                        "国产疫苗",
                        "恢复"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "37股获券商买入评级 隆华科技目标涨幅达54.48%",
                "features": {
                    "keywords": [
                        "券商买入评级",
                        "隆华科技",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "其他行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "股票跌停、业绩大增智飞生物“冰火两重天”",
                "features": {
                    "keywords": [
                        "股票跌停",
                        "业绩大增",
                        "智飞生物"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "公告隐现重大利好 周五8只个股有望突破大涨",
                "features": {
                    "keywords": [
                        "公告",
                        "重大利好",
                        "个股",
                        "大涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "其他行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物:净利润增速354%,重磅产品放量公司成长向好",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "净利润增速",
                        "重磅产品",
                        "放量",
                        "成长向好"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物:产品持续放量,行业震荡影响可控",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "产品放量",
                        "行业震荡",
                        "影响可控"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}